Huang Qingyan, Gan Yuhong, Zheng Xiaoqi, Yu Zhikang, Huang Qionghui, Huang Mingfeng
Institute of Cardiovascular Disease, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, China.
GuangDong Engineering Technological Research Center of Molecular Diagnosis in Cardiovascular Diseases, Meizhou, China.
BMC Cardiovasc Disord. 2025 Feb 17;25(1):104. doi: 10.1186/s12872-025-04571-5.
This study aimed to identify novel candidates that regulate Endothelial to mesenchymal transition(EndMT) in atherosclerosis by integrating multi-omics data.
The single-cell RNA sequencing (scRNA-seq) dataset GSE159677, bulk RNA-seq dataset GSE118446 and microarray dataset GSE56309 were obtained from the Gene Expression Omnibus (GEO) database. The uniform manifold approximation and projection (UMAP) were used for downscaling and cluster identification. Differentially expressed genes (DEGs) from GSE118446 and GSE56309 were analyzed using limma package. Functional enrichment analysis was applied by DAVID functional annotation tool. Quantitative real-time polymerase chain reaction (qPCR) and western blotting were used for further validation.
Nine endothelial cell (EC) clusters were identified in human plaques, with EC cluster 5 exhibiting an EndMT phenotype. The intersection of genes from EC cluster 5 and common DEGs in vitro EndMT models revealed seven mesenchymal candidates: PTGS2, TPM1, SERPINE1, FN1, RASD1, SEMA3C, and ESM1. Validation of these findings was carried out through qPCR analysis.
Through the integration of multi-omics data using bioinformatics methods, our study identified seven novel EndMT candidates: PTGS2, TPM1, SERPINE1, FN1, RASD1, SEMA3C, and ESM1.
本研究旨在通过整合多组学数据,鉴定在动脉粥样硬化中调节内皮-间充质转化(EndMT)的新候选基因。
从基因表达综合数据库(GEO)获取单细胞RNA测序(scRNA-seq)数据集GSE159677、批量RNA-seq数据集GSE118446和微阵列数据集GSE56309。使用均匀流形近似和投影(UMAP)进行降维和聚类识别。使用limma软件包分析来自GSE118446和GSE56309的差异表达基因(DEG)。通过DAVID功能注释工具进行功能富集分析。采用定量实时聚合酶链反应(qPCR)和蛋白质免疫印迹法进行进一步验证。
在人类斑块中鉴定出9个内皮细胞(EC)簇,其中EC簇5表现出EndMT表型。EC簇5中的基因与体外EndMT模型中常见DEG的交集揭示了7个间充质候选基因:PTGS2、TPM1、SERPINE1、FN1、RASD1、SEMA3C和ESM1。通过qPCR分析对这些发现进行了验证。
通过生物信息学方法整合多组学数据,我们的研究鉴定出7个新的EndMT候选基因:PTGS2、TPM1、SERPINE1、FN1、RASD1、SEMA3C和ESM1。